Thomas K. Schlesinger

729 total citations
9 papers, 597 citations indexed

About

Thomas K. Schlesinger is a scholar working on Molecular Biology, Ophthalmology and Cell Biology. According to data from OpenAlex, Thomas K. Schlesinger has authored 9 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Ophthalmology and 3 papers in Cell Biology. Recurrent topics in Thomas K. Schlesinger's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Melanoma and MAPK Pathways (3 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Thomas K. Schlesinger is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Melanoma and MAPK Pathways (3 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Thomas K. Schlesinger collaborates with scholars based in United States and Switzerland. Thomas K. Schlesinger's co-authors include Gary L. Johnson, Gary R. Fanger, Toshiaki Yujiri, Spencer B. Gibson, Christian Widmann, Matthew Jarpe, Timothy Garrington, Erwin W. Gelfand, Cindy Knall and David J. Wilson and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Biochemical Journal.

In The Last Decade

Thomas K. Schlesinger

9 papers receiving 582 citations

Peers

Countries citing papers authored by Thomas K. Schlesinger

Since Specialization

Citations

This map shows the geographic impact of Thomas K. Schlesinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas K. Schlesinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas K. Schlesinger more than expected).

Fields of papers citing papers by Thomas K. Schlesinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas K. Schlesinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas K. Schlesinger. The network helps show where Thomas K. Schlesinger may publish in the future.

Co-authorship network of co-authors of Thomas K. Schlesinger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas K. Schlesinger. A scholar is included among the top collaborators of Thomas K. Schlesinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas K. Schlesinger. Thomas K. Schlesinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	CULTURE-POSITIVE ENDOPHTHALMITIS 6 HOURS AFTER INTRAVITREAL ANTIBIOTICS 2010 ·Retinal Cases & Brief Reports ·Christina J. Flaxel, Thomas K. Schlesinger, Andreas Lauer	1
2	INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 2007 ·Retina ·Maxwell Emerson, Andreas Lauer, Christina J. Flaxel, David J. Wilson, Peter J. Francis, J. Timothy Stout, Geoffrey G. Emerson, Thomas K. Schlesinger, Susan K. Nolte, Michael L. Klein	140
3	Internal En Bloc Resection and Genetic Analysis of Retinal Capillary Hemangioblastoma 2007 ·Archives of Ophthalmology ·Thomas K. Schlesinger	21
4	Apoptosis Stimulated by the 91-kDa Caspase Cleavage MEKK1 Fragment Requires Translocation to Soluble Cellular Compartments 2002 ·Journal of Biological Chemistry ·Thomas K. Schlesinger, (unknown), Matthew Jarpe, Gary R. Fanger, Jean‐René Cardinaux, Gary L. Johnson, Christian Widmann	38
5	Platelet-derived growth factor-dependent association of the GTPase-activating protein of Ras and Src 1999 ·Biochemical Journal ·Thomas K. Schlesinger, Kris A. DeMali, Gary L. Johnson, Andrius Kazlauskas	20
6	MEK Kinase 1 (MEKK1) Transduces c-Jun NH2-terminal Kinase Activation in Response to Changes in the Microtubule Cytoskeleton 1999 ·Journal of Biological Chemistry ·Toshiaki Yujiri, Gary R. Fanger, Timothy Garrington, Thomas K. Schlesinger, Spencer B. Gibson, Gary L. Johnson	114
7	The TAO of MEKK 1998 ·Frontiers in bioscience ·Thomas K. Schlesinger	120
8	Anti-apoptotic versus pro-apoptotic signal transduction: Checkpoints and stop signs along the road to death 1998 ·Oncogene ·Matthew Jarpe, Christian Widmann, Cindy Knall, Thomas K. Schlesinger, Spencer B. Gibson, Toshiaki Yujiri, Gary R. Fanger, Erwin W. Gelfand, Gary L. Johnson	133
9	USE OF INTRANASAL MIDAZOLAM IN PRESCHOOL CHILDREN 1990 ·Anesthesia & Analgesia ·(unknown), (unknown), Thomas K. Schlesinger, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact